Skip to main content
Clinical Trials/ACTRN12615001192572
ACTRN12615001192572
Recruiting
未知

To explore the psychosocial function, fertility related quality of life, and the meaning of parenthood in young people with and without cancer as well as parents of cancer patients: A prospective study.

The Prince of Wales Foundation Grant0 sites150 target enrollmentNovember 4, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Fertility-related distress
Sponsor
The Prince of Wales Foundation Grant
Enrollment
150
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 4, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Prince of Wales Foundation Grant

Eligibility Criteria

Inclusion Criteria

  • \*Patients who consent to participate in the research study and are enrolled on the Australasian Oncofertility Registry
  • \*Parents or carers who have a child with cancer enrolled on the Australasian Oncofertility Registry
  • \*Aged matched controls aged 15\-25 years who consent to participate on the research study
  • For inclusion in this study, patients will be aged 15\-25 years, who have agreed to have their data stored on the Australasian Oncofertility Registry and have ticked on their consent form that they wish to participate in future studies and are happy to be contacted to participate on the FUTuRE Fertility Psychological Health Research study. Patients eligible to participate will be enrolled on the registry from between 0\-90 days from their cancer diagnosis. Partners/parents/carers of a participant in the cancer group will also be contacted separately to say that their child/partner has agreed to participate in this study and will offer them the opportunity at this stage, via letter to the parent/partner/carer, by the FUTuRE Fertility Clinical Psychologist, to participate in this study.
  • Controls aged 15\-25 years will be recruited via social media as well as from participating fertility sites enrolled on the Australasian Oncofertility Registry, to which ethics approval has been received for this study. The controls maybe visiting their fertility specialist for a number of different medical conditions such as: ovulation disorders (polycystic ovaries), uterine or cervical abnormalities, including problems with the opening of the cervix or cervical mucus, or abnormalities in the shape or cavity of the uterus (uterine fibroids), endometriosis, primary ovarian insufficiency, thyroid problems, abnormal sperm production or function due to various problems, such as undescended testicles, prior infections , trauma or prior surgeries on the testicles,
  • Both male and female non\-cancer consenting participants aged 15\-25 years will be matched by 5 year age\-periods and gender to consenting cancer survivors who are actively trying to have a family.
  • Once a patient, parent or partner, matched control consents to participate, they will be contacted by either the study psychologist or a member of the research team who will explain the research study in detail in order to verify the participant's willingness to participate. An interpreter will be made available if required by the hospital, at a cost incurred by the FUTuRE Fertility research steering group. It will also be explained to the participant that if at any stage of the research study (questionnaire/telephone interview) that a participant decides to decline or stop participation with either the questionnaire or telephone interview, they will be able to do so immediately without any repercussions.

Exclusion Criteria

  • \*Patients who do not consent to participate in the research study
  • \*Parents or carers who do not have a child with cancer enrolled on the Australasian Oncofertility Registry
  • \*Aged matched controls aged 15\-25 years who do not consent to participate on the research study who have or have previously had a cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials